BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18720216)

  • 21. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
    Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (1 --> 3)-beta-D-glucan--a new marker for the early serodiagnosis of deep-seated fungal infections in humans.
    Kedzierska A
    Pol J Microbiol; 2007; 56(1):3-9. PubMed ID: 17419183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
    Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009551. PubMed ID: 26424726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants.
    Zhao D; Qiu G; Luo Z; Zhang Y
    PLoS One; 2015; 10(4):e0123907. PubMed ID: 25874376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
    Pickering JW; Sant HW; Bowles CA; Roberts WL; Woods GL
    J Clin Microbiol; 2005 Dec; 43(12):5957-62. PubMed ID: 16333082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.
    Onishi A; Sugiyama D; Kogata Y; Saegusa J; Sugimoto T; Kawano S; Morinobu A; Nishimura K; Kumagai S
    J Clin Microbiol; 2012 Jan; 50(1):7-15. PubMed ID: 22075593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
    Ostrosky-Zeichner L; Alexander BD; Kett DH; Vazquez J; Pappas PG; Saeki F; Ketchum PA; Wingard J; Schiff R; Tamura H; Finkelman MA; Rex JH
    Clin Infect Dis; 2005 Sep; 41(5):654-9. PubMed ID: 16080087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of the (1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers.
    Son HJ; Sung H; Park SY; Kim T; Lee HJ; Kim SM; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    PLoS One; 2017; 12(11):e0188860. PubMed ID: 29190812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
    Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
    Cochrane Database Syst Rev; 2015 Sep; (9):CD009551. PubMed ID: 26343815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.
    De Vlieger G; Lagrou K; Maertens J; Verbeken E; Meersseman W; Van Wijngaerden E
    J Clin Microbiol; 2011 Nov; 49(11):3783-7. PubMed ID: 21880959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients.
    Singh N; Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Wagener MM; Wheat LJ
    Transplantation; 2015 Dec; 99(12):2543-50. PubMed ID: 26050015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of plasma (1-->3) beta-D-glucan concentrations in birds naturally and experimentally infected with aspergillus fumigatus.
    Burco JD; Ziccardi MH; Clemons KV; Tell LA
    Avian Dis; 2012 Mar; 56(1):183-91. PubMed ID: 22545545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.
    Hachem RY; Kontoyiannis DP; Chemaly RF; Jiang Y; Reitzel R; Raad I
    J Clin Microbiol; 2009 Jan; 47(1):129-33. PubMed ID: 19005145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
    Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
    Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The performance of (1, 3)-beta-D-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases].
    Horiguchi Y
    Kansenshogaku Zasshi; 2004 Jul; 78(7):566-73. PubMed ID: 15359888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of invasive fungal disease in hospitalized patients with chronic obstructive pulmonary disease.
    Mohedano Del Pozo RB; Rubio Alonso M; Cuétara García MS
    Rev Iberoam Micol; 2018; 35(3):117-122. PubMed ID: 30078525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.